Jack Branson is an aspiring journalist for a large publishing company. He is assigned to report on a government-supported medical scheme called Ever Young, a gene-editing procedure that promises to eliminate all genetic frailties and negative medical conditions. Those who commit to the scheme will be guaranteed good health until the age of 95, whereupon they would submit to the government’s terms of termination. Magnum, a world-famous German computer company, has taken control of the Ever Young scheme, and their deep pockets allow them control of the government. But Jack discovers Magnum’s deeply concerning wartime history. The corruption and violence that ensue when these eugenicists are entrusted with data of a now intimately networked world threaten the entire global order. Governments stand and fall by their capricious nature. Who dares to confront the truth? Although Ever Young is fictional it is loosely based on the true actions of a major multinational technology corporation who benefitted significantly from their involvement in the Holocaust.
David Sallon was born in 1938, and has spent the last fifty years inventing, manufacturing, and selling disposables to a global retail, industrial and medical world. Many of these items are now everyday essentials. His experiences have allowed him to negotiate with multinationals and espouse national trends. His eight children have followed in his tracks, often fighting the establishment with new ideas which benefit mankind. Ever Young has taken four years to write, and exposes the weaknesses of politicians who, tempted to benefit from their given responsibilities, get drawn into a web of criminal activity with disastrous results. Politics and medicine do in reality combine in a delicate cocktail that must be tempered by legislation and exposed by the press. But who should be in control? Without oversight of a non-governmental public health brains trust, there could be unforeseen consequences, when the fiction of Ever Young becomes fact. Previously published: Pschatts, 2012